Financhill
Sell
49

NVCR Quote, Financials, Valuation and Earnings

Last price:
$30.83
Seasonality move :
-8.57%
Day range:
$30.33 - $31.52
52-week range:
$11.70 - $34.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.74x
P/B ratio:
9.25x
Volume:
1.7M
Avg. volume:
1.6M
1-year change:
138.62%
Market cap:
$3.3B
Revenue:
$509.3M
EPS (TTM):
-$1.40

Earnings Data

Next earnings date for NVCR
Feb 21
2025
Most recent earnings per share
-$0.28
Beat by $0.05
(Oct 30/2024)
Consensus Estimate
-$0.33
(Oct 30/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NVCR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/21/2025 Q4 $153M -- -- -$0.36 --
10/30/2024 Q3 $143.9M $155.1M -$0.28 -$0.33 $0.05
07/25/2024 Q2 $135.8M $150.4M -$0.31 -$0.40 $0.09
05/02/2024 Q1 $131.4M $138.5M -$0.36 -$0.42 $0.06
02/22/2024 Q4 $133.8M $133.8M -$0.45 -$0.52 $0.07
10/26/2023 Q3 -- -- -$0.46 -$0.53 $0.07
07/27/2023 Q2 -- -- -$0.54 -$0.50 -$0.04
05/04/2023 Q1 -- -- -$0.50 -$0.34 -$0.16
02/23/2023 Q4 -- -- -$0.36 -$0.31 -$0.05
10/27/2022 Q3 -- -- -$0.25 -$0.26 $0.01
07/28/2022 Q2 -- -- -$0.23 -$0.14 -$0.09
04/28/2022 Q1 -- -- -$0.04 -$0.19 $0.15
02/24/2022 Q4 -- -- -$0.25 -$0.10 -$0.15
10/28/2021 Q3 -- -- -$0.13 -$0.06 -$0.07
07/29/2021 Q2 -- -- -$0.14 $0.01 -$0.15
04/29/2021 Q1 -- -- -$0.04 $0.01 -$0.05
02/25/2021 Q4 -- -- $0.04 $0.13 -$0.09
10/29/2020 Q3 -- -- $0.09 $0.04 $0.05
07/30/2020 Q2 -- -- $0.02 $0.01 $0.01
04/30/2020 Q1 -- -- $0.04 $0.03 $0.01
02/27/2020 Q4 -- -- $0.04 $0.00 $0.04
10/31/2019 Q3 -- -- $0.02 -$0.04 $0.06
07/25/2019 Q2 -- -- -$0.01 -$0.06 $0.05
05/02/2019 Q1 -- -- -$0.13 -$0.15 $0.02
02/28/2019 Q4 -- -- -$0.17 -$0.13 -$0.04
10/25/2018 Q3 -- -- -$0.13 -$0.14 $0.01
07/26/2018 Q2 -- -- -$0.17 -$0.16 -$0.01
04/26/2018 Q1 -- -- -$0.23 -$0.13 -$0.10
02/22/2018 Q4 -- -- -$0.12 -$0.12 $0.00
10/26/2017 Q3 -- -- -$0.13 -$0.14 $0.01
07/27/2017 Q2 -- -- -$0.24 -$0.22 -$0.02
04/27/2017 Q1 -- -- -$0.21 -$0.20 -$0.01

NovoCure Earnings Questions

  • How Much did NovoCure Generate in Revenue Last Quarter?

    NovoCure reported $155.1M worth of top line sales in its most recent quarter.

  • Did NovoCure Beat Earnings Last Quarter?

    NovoCure announced earnings per share of -$0.28 which represents a beat of analyst forecast a -$0.33 per share.

  • Is NovoCure Profitable?

    NovoCure reported $119.7M that represents $1.11 per share over the last quarter.

  • What is the Analyst Consensus for NovoCure EPS Next Year?

    NovoCure's earnings are forecast to decrease from -$1.95 per share to -$2.02 per share next year representing a decrease of -32.57%.

  • When is NovoCure's Earnings Date?

    NovoCure's next earnings date is February 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock